文献速递艾滋病与性传播感染

未治疗人类免疫缺陷病毒1型(HIV-1)感染全谱中的脑脊液病毒载量:一项横断面多中心研究

Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
PubMed 文献 · Clin Infect Dis · 2022-01-01

该多中心横断面研究纳入1018例未治疗且可获取脑脊液HIV-RNA的成人,分析不同疾病阶段脑脊液HIV-RNA的变化及其与血浆HIV-RNA和生物标志物的关联。脑脊液中位HIV-RNA较血浆低约1.03 log10 copies/mL,但在HIV相关痴呆或中枢神经系统机会性感染患者中可出现脑脊液-血浆不一致。

要点

  • 脑脊液HIV-RNA中位值较血浆低1.03 log10 copies/mL,且与血浆HIV-RNA、脑脊液新蝶呤、脑脊液白细胞计数及白蛋白比值相关。
  • HIV相关痴呆患者脑脊液HIV-RNA中位值最高,为4.73 log10 copies/mL。
  • 脑脊液病毒载量高于血浆的不一致见于126/972例(13%),在HIV相关痴呆患者中达30%。

核心结论

  • 研究证实不同HIV疾病阶段脑脊液HIV-RNA存在差异,总体脑脊液HIV-RNA较血浆低约1 log10 copies/mL,但相当少数受试者存在脑脊液不一致,最常见于HIV相关痴呆患者,提示随疾病进展中枢神经系统 compartmentalization 增加。

研究设计与样本

  • 多中心横断面研究,纳入1018例未治疗且可获取脑脊液HIV-RNA定量的成人,按代表显著疾病阶段分组。

主要发现

  • 脑脊液HIV-RNA中位(IQR)较血浆低1.03 log10(0.37-1.86)copies/mL。
  • 脑脊液HIV-RNA与血浆HIV-RNA相关(r=0.44,P<.01),与脑脊液新蝶呤(r=0.49,P<.01)、血清新蝶呤(r=0.29,P<.01)、脑脊液白细胞计数(r=0.34,P<.01)及白蛋白比值(r=0.25,P<.01)相关。
  • 除晚期免疫缺陷(CD4<200)的无神经症状患者及HIV相关痴呆或中枢神经系统机会性感染患者外,各组的脑脊液HIV-RNA与血浆HIV-RNA平行。
  • HIV相关痴呆患者脑脊液HIV-RNA中位(IQR)最高,为4.73(3.84-5.35)log10 copies/mL。
  • 脑脊液病毒载量高于血浆的不一致见于126/972例(13%),各组间从原发性HIV感染的1%、无神经症状组的11%至HIV相关痴呆患者的30%不等。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this large multicenter study was to determine variations in cerebrospinal fluid (CSF) HIV-RNA in different phases of untreated human immunodeficiency virus type 1 (HIV-1) infection and its associations with plasma HIV-RNA and other biomarkers. METHODS: Treatment naive adults with available CSF HIV-RNA quantification were included and divided into groups representing significant disease phases. Plasma HIV-RNA, CSF white blood cell count (WBC), neopterin, and albumin ratio were included when available. RESULTS: In total, 1018 patients were included. CSF HIV-RNA was in median (interquartile range [IQR]) 1.03 log10 (0.37-1.86) copies/mL lower than in plasma, and correlated with plasma HIV-RNA (r = 0.44, P < .01), neopterin concentration in CSF (r = 0.49, P < .01) and in serum (r = 0.29, P < .01), CSF WBC (r = 0.34, P < .01) and albumin ratio (r = 0.25, P < .01). CSF HIV-RNA paralleled plasma HIV-RNA in all groups except neuroasymptomatic patients with advanced immunodeficiency (CD4 < 200) and patients with HIV-associated dementia (HAD) or opportunistic central nervous system (CNS) infections. Patients with HAD had the highest CSF HIV-RNA (in median [IQR] 4.73 (3.84-5.35) log10 copies/mL). CSF > plasma discordance was found in 126 of 972 individuals (13%) and varied between groups, from 1% in primary HIV, 11% in neuroasymptomatic groups, up to 30% of patients with HAD. CONCLUSIONS: Our study confirms previous smaller observations of variations in CSF HIV-RNA in different stages of HIV disease. Overall, CSF HIV-RNA was approximately 1 log10 copies/mL lower in CSF than in plasma, but CSF discordance was found in a substantial minority of subjects, most commonly in patients with HAD, indicating increasing CNS compartmentalization paralleling disease progression.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ulfhammer G, Edén A, Antinori A, et al. Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study. Clin Infect Dis. 2022. PMID: 34747481. doi:10.1093/cid/ciab943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。